CLINICAL TRIALS PROFILE FOR GALAFOLD
✉ Email this page to a colleague
All Clinical Trials for GALAFOLD
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00214500 ↗ | A Study of AT1001 (Migalastat Hydrochloride) in Participants With Fabry Disease | Completed | Amicus Therapeutics | Phase 2 | 2006-01-02 | Study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of migalastat hydrochloride (HCl) (migalastat) in participants with Fabry disease. |
NCT00283933 ↗ | A 24-Week Safety and Pharmacodynamic Study of AT1001 (Migalastat Hydrochloride) in Participants With Fabry Disease | Completed | Amicus Therapeutics | Phase 2 | 2006-05-09 | Study to evaluate the safety, tolerability, and pharmacodynamics of migalastat hydrochloride (HCl) (migalastat) in participants with Fabry disease. |
NCT00283959 ↗ | A 12-Week Safety and Pharmacodynamic Study of AT1001 (Migalastat Hydrochloride) in Participants With Fabry Disease | Completed | Amicus Therapeutics | Phase 2 | 2006-06-27 | Study to evaluate the safety, tolerability, and pharmacodynamics of migalastat hydrochloride (HCl) (migalastat) and how migalastat works in participants with Fabry disease. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for GALAFOLD
Condition Name
Clinical Trial Locations for GALAFOLD
Trials by Country
Clinical Trial Progress for GALAFOLD
Clinical Trial Phase
Clinical Trial Sponsors for GALAFOLD
Sponsor Name